Position in HALO
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$65,316,315
+$51,599,117 QoQ
Shares Held
834,500
+132.3% QoQ
Ownership
0.735%
of shares outstanding
% of Portfolio
2.67%
of 13F equity value
Holder Rank
#41
of 664 holders
Holding Since
Mar 2023
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mizuho Markets Cayman LP holds $70,418,081 across 2 Biotechnology names. HALO ranks #1 (92.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
This page
|
834,500 | $65,316,315 | |
| 2 | NAMS |
NewAmsterdam Pharma Co N.V.
|
150,539 | $5,101,766 |
All Filings in HALO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $65,316,315 | 834,500 | Shares | Defined | 2026-07-24 | |
| 2023-03-31 | $13,717,198 | 359,183 | Shares | Defined | 2023-05-03 | |
| No filing history on record for this holder in this stock. | ||||||